MedPath

Perfusion Reserve of Stenotic Coronary Artery with Cardiac Computer Tomography in Patients with Hemodialysis.

Completed
Conditions
Patients with chronic renal failure suspected of effort angina
Registration Number
jRCTs031180349
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

A. The male or female (no pregnancy) patients (ages: thirty to eighty five) with hemodialysis for more than one year. B. The patients with suspected or proven coronary artery disease.
C and Written informed consent

Exclusion Criteria
  1. Iodine allergy
  2. Nephropathy with contrast media
  3. Multiple myeloma or organ transplantation 4.II or III degree complete AV block 5.Severe heart disease (III or IV in NYHA classification), diagnosis or suspected moderate or severe aortic stenosis 6.Coronary artery bypass graft or cardiac surgery 7.PCI within 6 months 8 or 9. incompatible beta blocker use or drug allergy with beta blocker
  4. Asthma
  5. Severe COPD with Inhalants bronchodilators
  6. Chief research doctor decide that the diseases which are not appropriate for this study.
  7. A history of severe exposure within eighteen months: the patients was exploded more than 50 mSV or was performed more than 2 times by radioisotope study or computer tomography.
  8. Acute coronary syndrome.
  9. incompatible vasodilators use: Systolic blood pressure less than 90 mmHg. Dipyridamole or Methylate norre xanthine use Acute coronary syndrome, recent myocardial infarction, and sinus bradycardia less than 40 bpm,
  10. Body mass index more than 40.
  11. Severe liver disease or heart disease which influence the absorption and metabolism of adenosine.
  12. Research doctor decide that the patient is not appropriate for this study.

Study & Design

Study Type
Interventional
Study Design
parallel assignment
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.